Maravai Lifesciences Holdings (MRVI) Profit After Tax Growth (1y) (2021 - 2026)
Maravai Lifesciences Holdings (MRVI) Profit After Tax Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | -88.68% |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 66.06% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 17.05% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -290.15% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | -129.68% |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -632.44% |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 59.59% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 743.11 Mn | 734.71 Mn | 33.70 Mn | 92.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 92.94% |
| Dec 31, 2025 | -46.19% |
| Sep 30, 2025 | 73.87% |
| Jun 30, 2025 | -279.14% |
| Mar 31, 2025 | -337.60% |
| Dec 31, 2024 | 162.47% |
| Sep 30, 2024 | -1,041.93% |
| Jun 30, 2024 | -181.61% |
| Mar 31, 2024 | -17,926.87% |
| Dec 31, 2023 | -392.24% |
| Sep 30, 2023 | -133.96% |
| Jun 30, 2023 | -109.18% |
| Mar 31, 2023 | -100.05% |
| Dec 31, 2022 | -32.59% |
| Sep 30, 2022 | -17.59% |
| Jun 30, 2022 | 44.96% |
| Mar 31, 2022 | 94.61% |
| Dec 31, 2021 | 388.41% |
| Sep 30, 2021 | 38.54% |
| Jun 30, 2021 | 3,307.98% |